About BrightInsight

BrightInsight provides a regulated digital health platform that enables biopharma and medtech companies to develop and manage Software as a Medical Device (SaMD) solutions, including companion apps and connected products. The platform enhances patient care by delivering measurable clinical and business outcomes, improving patient adoption and retention across various therapy areas.

```xml <problem> Biopharmaceutical and medical technology companies face challenges in developing, managing, and scaling digital health solutions, including Software as a Medical Device (SaMD) and companion apps, within a regulated environment. These companies need to ensure compliance, security, and interoperability while demonstrating measurable clinical and business outcomes. </problem> <solution> BrightInsight offers a regulated digital health platform designed to enable biopharma and medtech organizations to build, scale, and optimize their digital health offerings. The platform supports the development and management of SaMD solutions, such as companion apps and connected products, across various therapy areas. By leveraging the BrightInsight platform, life science companies can deliver measurable clinical and business results, improve patient adoption and retention, and differentiate their therapies through real-world data integration. </solution> <features> - Pre-built infrastructure compliant with HIPAA, GDPR, and other global regulations - Modular architecture for rapid development and deployment of digital health applications - Secure data storage and transmission with end-to-end encryption - Integration capabilities with electronic health records (EHRs) and other healthcare systems - Real-world data (RWD) connectivity for generating insights and improving patient outcomes - Device connectivity for integration with connected combination products - Analytics dashboards for monitoring key performance indicators (KPIs) and tracking patient engagement </features> <target_audience> The primary target audience includes biopharmaceutical and medical technology companies seeking a compliant and scalable platform for developing and managing their digital health solutions. </target_audience> ```

What does BrightInsight do?

Where is BrightInsight located?

BrightInsight is based in Sunnyvale, United States.

When was BrightInsight founded?

BrightInsight was founded in 2017.

How much funding has BrightInsight raised?

BrightInsight has raised 201160000.

Location

Sunnyvale, United States

Founded

2017

Funding

201160000

Employees

177 employees

Major Investors

General Catalyst

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

BrightInsight

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

brightinsight.com 10K+

Crunchbase

Founded 2017 – Sunnyvale, United States

Funding

Estimated Funding

$200M+

Major Investors

General Catalyst

Team (100+)

No team information available.

Company Description

Problem

Biopharmaceutical and medical technology companies face challenges in developing, managing, and scaling digital health solutions, including Software as a Medical Device (SaMD) and companion apps, within a regulated environment. These companies need to ensure compliance, security, and interoperability while demonstrating measurable clinical and business outcomes.

Solution

BrightInsight offers a regulated digital health platform designed to enable biopharma and medtech organizations to build, scale, and optimize their digital health offerings. The platform supports the development and management of SaMD solutions, such as companion apps and connected products, across various therapy areas. By leveraging the BrightInsight platform, life science companies can deliver measurable clinical and business results, improve patient adoption and retention, and differentiate their therapies through real-world data integration.

Features

Pre-built infrastructure compliant with HIPAA, GDPR, and other global regulations

Modular architecture for rapid development and deployment of digital health applications

Secure data storage and transmission with end-to-end encryption

Integration capabilities with electronic health records (EHRs) and other healthcare systems

Real-world data (RWD) connectivity for generating insights and improving patient outcomes

Device connectivity for integration with connected combination products

Analytics dashboards for monitoring key performance indicators (KPIs) and tracking patient engagement

Target Audience

The primary target audience includes biopharmaceutical and medical technology companies seeking a compliant and scalable platform for developing and managing their digital health solutions.